This study investigates pancreatic cancer. It looks at how a four-week multimodal prehabilitation program affects patients who are scheduled for curative surgery.

This study evaluates the impact of prehabilitation on postoperative outcomes, functional and nutritional status, and quality of life. It also examines its effect on certain biomarkers related to muscle wasting and cancer cachexia.

• Who can participate: Adults aged 18 years or older with an indication for curative resection for pancreatic or periampullary cancer can participate. Participants must sign informed consent. Those with metastatic disease, certain comorbidities, or who are pregnant are excluded.
• Study details: Participants will either receive a prehabilitation program or no prehabilitation. The program includes exercise, nutritional therapy, and anxiety-reducing techniques.
• Study timelines and visits: The study will last 90 days. The study requires 3 visits.